Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ear, Inner | 7 | 2025 | 17 | 2.290 |
Why?
|
| Endoscopy | 5 | 2021 | 112 | 1.770 |
Why?
|
| Cochlea | 4 | 2018 | 22 | 1.590 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 49 | 1.500 |
Why?
|
| Round Window, Ear | 1 | 2025 | 1 | 0.960 |
Why?
|
| Drug Delivery Systems | 4 | 2025 | 329 | 0.920 |
Why?
|
| Temporal Bone | 4 | 2025 | 39 | 0.900 |
Why?
|
| Hair Cells, Auditory | 4 | 2025 | 15 | 0.890 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2025 | 22 | 0.730 |
Why?
|
| Genetic Therapy | 2 | 2025 | 802 | 0.670 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 48 | 0.650 |
Why?
|
| Hearing Loss, Central | 1 | 2020 | 2 | 0.650 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 24 | 0.640 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 32 | 0.640 |
Why?
|
| Speech | 1 | 2020 | 63 | 0.630 |
Why?
|
| Speech Perception | 1 | 2020 | 79 | 0.600 |
Why?
|
| Receptor, trkB | 1 | 2018 | 7 | 0.560 |
Why?
|
| Diphosphonates | 1 | 2018 | 33 | 0.560 |
Why?
|
| Hearing Loss | 2 | 2018 | 64 | 0.540 |
Why?
|
| Spiral Ganglion | 4 | 2023 | 11 | 0.540 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 77 | 0.530 |
Why?
|
| Neuroma, Acoustic | 1 | 2017 | 13 | 0.520 |
Why?
|
| Nasal Obstruction | 1 | 2016 | 4 | 0.510 |
Why?
|
| Nasal Surgical Procedures | 1 | 2016 | 4 | 0.510 |
Why?
|
| Stem Cells | 2 | 2016 | 262 | 0.500 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 33 | 0.490 |
Why?
|
| Health Personnel | 1 | 2020 | 389 | 0.490 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2016 | 61 | 0.470 |
Why?
|
| Pandemics | 1 | 2020 | 676 | 0.460 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 318 | 0.450 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 671 | 0.440 |
Why?
|
| Hair Cells, Auditory, Inner | 2 | 2023 | 5 | 0.380 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2025 | 1669 | 0.350 |
Why?
|
| Otologic Surgical Procedures | 2 | 2021 | 18 | 0.350 |
Why?
|
| Humans | 19 | 2025 | 64279 | 0.260 |
Why?
|
| Cell Differentiation | 3 | 2025 | 1365 | 0.250 |
Why?
|
| Cochlear Nerve | 2 | 2018 | 8 | 0.240 |
Why?
|
| Animals | 13 | 2025 | 20962 | 0.240 |
Why?
|
| Mice | 9 | 2025 | 11003 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2025 | 644 | 0.220 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2021 | 9 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 2 | 2023 | 123 | 0.210 |
Why?
|
| Pneumocephalus | 1 | 2023 | 8 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 288 | 0.200 |
Why?
|
| Drugs, Investigational | 1 | 2023 | 12 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 224 | 0.200 |
Why?
|
| Aphasia | 1 | 2023 | 46 | 0.190 |
Why?
|
| Child, Preschool | 2 | 2025 | 2019 | 0.190 |
Why?
|
| Meniere Disease | 2 | 2019 | 14 | 0.180 |
Why?
|
| Infant, Newborn | 1 | 2025 | 1375 | 0.170 |
Why?
|
| Infant | 1 | 2025 | 1664 | 0.170 |
Why?
|
| Regeneration | 1 | 2021 | 101 | 0.160 |
Why?
|
| Analgesics | 1 | 2020 | 102 | 0.160 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2021 | 128 | 0.160 |
Why?
|
| Neuroglia | 1 | 2020 | 80 | 0.150 |
Why?
|
| Endolymphatic Sac | 1 | 2019 | 1 | 0.150 |
Why?
|
| Vestibular Aqueduct | 1 | 2019 | 2 | 0.150 |
Why?
|
| Cadaver | 2 | 2018 | 129 | 0.150 |
Why?
|
| Equipment Design | 1 | 2020 | 362 | 0.150 |
Why?
|
| Vestibular Nerve | 1 | 2018 | 13 | 0.140 |
Why?
|
| Denervation | 1 | 2018 | 19 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2016 | 2177 | 0.140 |
Why?
|
| Chorea | 2 | 2008 | 10 | 0.140 |
Why?
|
| Child | 2 | 2025 | 4583 | 0.140 |
Why?
|
| Neurites | 1 | 2018 | 23 | 0.140 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2008 | 51 | 0.140 |
Why?
|
| Adolescent | 3 | 2025 | 6305 | 0.140 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2018 | 41 | 0.140 |
Why?
|
| Genome | 2 | 2017 | 276 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 80 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2018 | 64 | 0.130 |
Why?
|
| Labyrinth Diseases | 1 | 2016 | 3 | 0.130 |
Why?
|
| Decision Trees | 1 | 2016 | 50 | 0.130 |
Why?
|
| Neurons | 2 | 2020 | 934 | 0.120 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 7 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2018 | 1020 | 0.120 |
Why?
|
| Male | 6 | 2025 | 30323 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 138 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 77 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 110 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 685 | 0.110 |
Why?
|
| Female | 6 | 2025 | 33382 | 0.110 |
Why?
|
| Cochlear Nucleus | 1 | 2014 | 1 | 0.110 |
Why?
|
| Auditory Pathways | 1 | 2014 | 8 | 0.110 |
Why?
|
| Optogenetics | 1 | 2014 | 32 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 487 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2020 | 2605 | 0.110 |
Why?
|
| Atlases as Topic | 1 | 2014 | 12 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2016 | 362 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 783 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2016 | 627 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 66 | 0.100 |
Why?
|
| Osteoprotegerin | 1 | 2013 | 5 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2025 | 6742 | 0.100 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2013 | 3 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2020 | 3318 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 72 | 0.100 |
Why?
|
| Wnt3A Protein | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cholera | 1 | 2012 | 14 | 0.090 |
Why?
|
| Stria Vascularis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Organ of Corti | 1 | 2011 | 4 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 129 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 82 | 0.080 |
Why?
|
| Transcriptome | 1 | 2014 | 396 | 0.080 |
Why?
|
| Glucose | 2 | 2008 | 471 | 0.070 |
Why?
|
| Anemia, Hemolytic | 1 | 2008 | 13 | 0.070 |
Why?
|
| Cations | 1 | 2008 | 64 | 0.070 |
Why?
|
| Epilepsy | 1 | 2008 | 110 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2025 | 883 | 0.060 |
Why?
|
| Adult | 4 | 2019 | 17133 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2025 | 2140 | 0.060 |
Why?
|
| Mice, Inbred CBA | 2 | 2014 | 83 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 375 | 0.050 |
Why?
|
| Ear Canal | 1 | 2021 | 10 | 0.050 |
Why?
|
| Ear, Middle | 1 | 2021 | 22 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2012 | 245 | 0.040 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2020 | 7 | 0.040 |
Why?
|
| Aging | 2 | 2019 | 754 | 0.040 |
Why?
|
| Mutation | 1 | 2008 | 2629 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 349 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 56 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1621 | 0.040 |
Why?
|
| Fetus | 1 | 2019 | 100 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1551 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2016 | 7 | 0.030 |
Why?
|
| Phenotype | 2 | 2013 | 1222 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 334 | 0.030 |
Why?
|
| Tinnitus | 1 | 2016 | 19 | 0.030 |
Why?
|
| Inferior Colliculi | 1 | 2014 | 1 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2014 | 3 | 0.030 |
Why?
|
| Auditory Cortex | 1 | 2014 | 6 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2014 | 9 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 52 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 3450 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2014 | 139 | 0.030 |
Why?
|
| Action Potentials | 1 | 2014 | 111 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2014 | 19 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 51 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 85 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 173 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 196 | 0.030 |
Why?
|
| Plastic Embedding | 1 | 2013 | 1 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2013 | 9 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2013 | 17 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 263 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 3726 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 215 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2738 | 0.020 |
Why?
|
| Thermolysin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 161 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2012 | 6 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 577 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 44 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 458 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 2370 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 82 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 103 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 490 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 582 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 304 | 0.020 |
Why?
|
| Myosins | 1 | 2012 | 115 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 192 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 901 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 668 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 240 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5697 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2055 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1257 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5528 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1297 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 23 | 0.020 |
Why?
|
| Xenopus | 1 | 2008 | 55 | 0.020 |
Why?
|
| Physical Exertion | 1 | 2008 | 81 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 195 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 197 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1094 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2008 | 151 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2008 | 150 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 17923 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 290 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 220 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 760 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1540 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2008 | 487 | 0.010 |
Why?
|
| Biomarkers | 1 | 2011 | 1431 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1597 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1997 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14664 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1187 | 0.010 |
Why?
|
| Exercise | 1 | 2008 | 954 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 2218 | 0.010 |
Why?
|